In tumor studies such as glioblastoma multiforme, hypomethylated and highly expressed PARVB may be involved in the process of epithelial to mesenchymal transition (EMT) and significantly associated with poor prognosis, making it a potential target for tumors [43]. This evidence concerns the gene PARVB and neoplasm.